Walleye Capital
SANA icon

Walleye Capital’s Sana Biotechnology SANA Stock Holding History

Walleye Capital’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.9K Buy
+10,000
New +$32.2K ﹤0.01% 4283
2025
Q4 		– Sell
-77,080
Closed -$274K – 5051
2025
Q3 		$274K Buy
+77,080
New +$279K ﹤0.01% 3088
2025
Q1 		– Sell
-93,383
Closed -$152K – 5029
2024
Q4 		$152K Buy
+93,383
New +$278K ﹤0.01% 3922

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Walleye Capital's SANA Position: Q2 2026 in Review

Walleye Capital opened a new position in Sana Biotechnology (SANA) in Q2 2026: 10,000 shares worth $34.9K. The stake represents ﹤0.01% of the portfolio and ranks #4283 among its holdings. This is a return to the name: Walleye Capital previously reported a position in SANA as recently as Q3 2025.

Walleye Capital first reported a position in SANA in Q4 2024 and has held it in 3 quarters since. The position peaked at $274K in Q3 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Walleye Capital held 10,000 shares of Sana Biotechnology worth $34.9K as of Q2 2026.
  • Sana Biotechnology was a new Walleye Capital position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4283 holding.
  • Walleye Capital first reported a position in Sana Biotechnology in Q4 2024 and has held it in 3 quarters since.
  • Walleye Capital's Sana Biotechnology position peaked at $274K in Q3 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.